TIG Advisors LLC’s Centessa Pharmaceuticals CNTA Stock Holding History

TIG Advisors LLC’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-648,326	Closed	-$25.8M	–	116
2026 Q1	$25.8M	Buy	+648,326	New	+$16.6M	1.19%	25

TIG Advisors LLC's CNTA Position: Q2 2026 in Review

TIG Advisors LLC sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 648,326 shares — an estimated $25.8M sold.

TIG Advisors LLC first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $25.8M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

TIG Advisors LLC reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
TIG Advisors LLC sold 648,326 Centessa Pharmaceuticals shares in Q2 2026, an estimated $25.8M.
TIG Advisors LLC first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
TIG Advisors LLC's Centessa Pharmaceuticals position peaked at $25.8M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on TIG Advisors LLC's 13F filing for Q2 2026, filed 14 Aug 2026.